Biopharma Co. Looks to Expand New Drug Label Down the Road
  (7/18/22)
ScPharmaceuticals Inc. just released topline results from a Phase 2 pilot study supporting the drug developer that is pursuing the expansion of its new drug label, noted an H.C. Wainwright & Co. report. More >

LIT Lithium Discovery Could Light Up Share Price
Source: Streetwise Reports  (7/18/22)
Lithium carbonate prices are up 340% year-over-year and one lithium junior explorer operating in Argentina just drilled some healthy lithium grades in a salar that extends beyond its property boundary and onto the junior's concessions. More >

Canada Firm Holds Promising Assets in 'Lithium Triangle'
Source: Streetwise Reports  (7/18/22)
Fundamental Research Corp. mentioned in a research note that this company is on a clear path to a potential new discovery in Argentina. The firm stated that it expects that a maiden resource estimate for its properties will be completed next year and is initiating coverage with a "Buy" rating. More >

Renewed Advance Imminent as Banks Create More Cash to Shore Up Debt
Source: Clive Maund  (7/18/22)
Expert Clive Maund examines the confluence of increasing debt and the precious metals sector and speculates on how the European Central Bank's plan to engage in "unlimited bond buying" will impact the market. More >

Junior 'Swings for Fences' in Golden Triangle
Source: Streetwise Reports  (7/15/22)
StrikePoint Gold Inc. is "laser-focused" on its Porter Idaho and Willoughby properties in British Columbia's Golden Triangle. More >

Healthcare Co.’s Psychedelic-Assisted Treatments Have ‘Blockbuster Drug Potential’
Source: Patrick Trucchio  (7/15/22)
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD. More >

Pharma Co. Reduces Mortality Rates by 70% in ALS Trial
Source: Streetwise Reports  (7/15/22)
Shares of Clene Inc. traded 38% higher yesterday after the company reported that its CNM-Au8 was shown to significantly decrease mortality in its RESCUE-ALS long-term extension trial. More >

eVTOL Aircraft Firm Secures Deal With Major US Airline
Source: Streetwise Reports  (7/15/22)
Vertical Aerospace Ltd.'s shares traded 70% higher after the eVTOL aircraft designer and manufacturer reported it secured a pre-delivery payment commitment from American Airlines Group for the first 50 units of its VX4 eVTOL aircraft. The firm also advised it received a separate order for 50 VX4s from a business jet operator in Belgium. More >

Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry
Source: Jason McCarthy  (7/14/22)
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report. More >

Green Tech's 'Bugs' to Find Gold in Ecuador
Source: Streetwise Reports  (7/14/22)
This green tech company will use its rock-eating bugs to process gold from mining production in Ecuador—and possibly somewhere near you. More >

Biopharma Co. Posts 17% BMI Reduction in Ph. 2 Trial
Source: Streetwise Reports  (7/14/22)
Shares of Rhythm Pharmaceuticals Inc. rose by over 30% after the company posted positive interim results from its Phase 2 clinical study of setmelanotide in hypothalamic obesity. The data shows that after 16 weeks of treatment with setmelanotide, patients experienced a 17.2% mean reduction in BMI and a mean weight loss of 15.8%. More >

Gold Junior Poised for Breakout
Source: Clive Maund   (7/14/22)
Technical Analyst Clive Maund explains why this junior gold explorer in Papua New Guinea that is gearing up to go far is a Buy in his book. More >

Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co.
Source: Andrew Partheniou  (7/13/22)
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments. More >

Milestones Reached at British Columbia Gold Asset
  (7/13/22)
At this project in a historical mining district, extensive mine preparations were completed, then mining and processing of placer gold commenced, which "could be a major catalyst for the stock." More >

Updated PFS May Pave Way to Partnership
Source: Streetwise Reports  (7/13/22)
A simpler open-pit only mine plan for Seabridge Gold’s massive KSM copper-gold project in northern B.C. could attract a joint-venture partner. But it might not be the company you think. More >

EV Maker Signs Agreement With Walmart for Up to 10,000 LDVs
Source: Streetwise Reports  (7/12/22)
Shares of Canoo Inc. traded 57% higher after the company reported that Walmart has contracted to purchase 4,500 of its electric Lifestyle Delivery Vehicles for use in its growing e-commerce business. The agreement includes an option for 5,500 additional units. More >

Three Analysts Like Healthcare Co.'s Upside
Source: Streetwise Reports  (7/11/22)
It is difficult to get three people to agree on anything, let alone three investment analysts. But that is precisely the case with one junior biotech company that has shown in a clinical trial that its ketamine-assisted therapy for alcohol use disorder (AUD) is three times more effective than the current standard of care. More >

Pharma Looks To Improve Potential Psychedelic Stroke Drug
Source: Streetwise Reports  (7/11/22)
Can a psychedelic compound help you heal after a stroke? This biopharmaceutical company hopes it can and plans to start Phase 1 trials this September. More >

EV Co. Secures Huge No. of Orders for Off-Road Vehicle
Source: Streetwise Reports  (7/11/22)
Shares of Volcon Inc. traded 47% after the all-electric powersports company reported that over the course of just 14 days it received thousands of pre-orders for its class-leading 125 hp Stag EV. The orders are expected to provide the firm with an additional $70 million in revenue. More >

Gold Co. Positioned To Be Next Tier One Asset in Ontario
Source: Maurice Jackson  (7/11/22)
Expert Maurice Jackson sits down with the CEO of Goldshore Resources Inc., Brett Richards to go over the latest updates with the company. With just one year under its belt, Goldshore Resources is already positioning itself to become the next tier one asset in Ontario. The flagship Moss Lake Property has a historical resource with significant expansion potential and is currently undergoing a 100,000-meter drill program, with impressive initial assay results. More >

Altius Invests in Lara Exploration
Source: Adrian Day  (7/11/22)
Expert Adrian Day reviews updates at some of his favorite companies, including most recently the news between Altius Minerals Corp. and Lara Exploration Ltd.'s relationship. More >

Oil Price Problem? Expert Says Look to 2011
Source: Michael J. Ballanger  (7/11/22)
Expert Michael Ballanger reviews this week's updates in the oil and gas sector, specifically his view on the U.S. government's handling of sanctions against Russia and how that will impact the economy. More >

New Drug Is Shown to Help Stopped or Reduced Bile Flow
  (7/10/22)
Albireo Pharma Inc.'s positive Phase 3 trial results indicate the medication would afford patients clinical and quality of life benefits, noted an H.C. Wainwright & Co. report. More >

New DMD Drug Yields 'Compelling' Data
  (7/9/22)
A statistical reanalysis of trial results from Sarepta Therapeutics Inc. shows improved patient function, noted an Oppenheimer report. More >

Amended Agreement to Benefit Two Biotech Firms
  (7/8/22)
In the new arrangement between Beam Therapeutics Inc. and Verve Therapeutics Inc. each of the companies grants the other an exclusive license, one to a base editing target, the other to a gene delivery technology, noted a Wedbush report. More >